Home / Sustainability / Stakeholder Communication

Stakeholder Communication

Partnership. two business people shaking hand after business job interview in meeting room at office, congratulation, investor, success, interview, partnership, teamwork, financial, connection concept

Stakeholder Identification and Engagement

Bora utilizes cross-departmental collaboration and monthly communications, following the AA1000 SES Stakeholder Engagement Standard, to identify 6 categories of stakeholders: employees, investors, customers, suppliers, communities, and government entities. Addressing the respective concerns of each stakeholder group, the Company assesses relevance through the implementation of sustainability strategic projects to continuously enhance communication effectiveness. In addition, Bora submits stakeholder engagement outcomes to the Board of Directors on an annual basis to enhance transparency as part of its corporate governance endeavors.

StakeholderCommunication Channels, Response Methods and Frequency2025 Communication Results
Employees
  • Department communication and mission-group meetings (daily)
  • Site level meetings (weekly)
  • Internal e-newsletter (monthly)
  • Employee general meetings (quarterly)
  • Labor-management committee meetings (quarterly)
  • Occupational Safety and Health Committee meetings (quarterly)
  • Performance appraisal interviews (annually)
  • Occupational safety and health education and training (annually)
  • Employee Welfare Committee meetings (quarterly)
  • Compensation Committee meetings (at least twice a year)
  • Employee training programs (time to time)
  • Employee suggestion box and complaint mailbox (real-time)
  • Internal website (time to time)
  • 4 employee general meetings to communicate major policies and operational goals
  • 4 labor-management committee meetings
  • 100% employee health examination coverage
  • 1,296 participants in Bora Family Day
  • 12 monthly issues of the internal Employee Newsletter
  • Third-party grievance and whistleblowing platform in operation
Investors
  • Annual General Shareholders’ Meeting (annually)
  • Corporate investor conferences (semiannually)
  • Investor forums (time to time)
  • Financial reports (quarterly)
  • Revenue performance disclosure (monthly)
  • Disclosure of material financial and business information on the Market Observation Post System (time to time)
  • Designated spokesperson, deputy spokesperson and media contact (real-time)
  • Dedicated investor relations mailbox and contact window (real-time)
  • Held 1 general shareholders’ meeting
  • Held 9 corporate investor conferences
  • Held 91 investor meetings
  • Disclosed 136 material announcements in both Chinese and English on the Market Observation Post System
Customers
  • Customer audits
  • Corporate website
  • Customer service email (real-time)
  • Business information provided through website and social media platforms (time to time)
  • E-newsletters (time to time)
  • Face-to-face events: health seminars, patient support groups, conferences and product briefings (time to time)
  • CDMO Business
    • Completed 40 global customer on-site inspections.
  • Global Sales Business
    • Received 278 customer complaints concerning prescription drugs and 623 complaints concerning consumer products. All complaints were addressed.
  • Pharmacovigilance
    • Received 1,042 adverse event reports.
    • Submitted 663 15-day reports, maintaining an on-time compliance submission rate of 99.55%.
    • Submitted 251 non-15-day reports, maintaining an on-time compliance submission rate of 98.01%.
StakeholderCommunication Channels, Response Methods and Frequency2025 Communication Results
Suppliers
  • Supplier management is conducted in accordance with SOPs; raw materials and excipients are purchased from vendors listed in the approved and verified supplier list
  • In accordance with PIC/S regulations, periodic audits of suppliers involved in GMP-related activities are conducted based on historical audit results and risk assessments

Completion of the 2025 supplier assessment

Supplier ESG management assessment conducted

Supplier Code of Conduct clearly defined

Communities
  • Community service activities (at least once per site annually)
  • Public welfare events (at least one per market annually)
  • Corporate website (real-time)
  • Social media platforms (real-time)
  • Donated NT$200,000 to the Taiwan Parkinson’s Disease Association, benefiting 100 Parkinson’s patients
  • Invited 150 faculty and students from four universities to visit the manufacturing sites for industry-academia exchange
  • Sponsored the Red Nose Clown Care Association with a contribution of NT$170,000, serving 59 children with a total of 173 service engagements
  • Supported neighboring schools by helping 240 underprivileged children fulfill their Christmas wishes
  • Partnered with Hsuan Liu’s podcast to launch a juvenile mental health series, reaching a total of 136,000 listeners
  • Donated to the Taiwan Blood Services Foundation
  • A voluntary donation from employees with a matching contribution from the Company, totaling NT$1 million, for Hualien disaster relief
Government 
  • Regulatory compliance meetings (as needed)
  • Policy briefings (as needed)
  • Official correspondence (as needed)
  • Government inspections and audits (as scheduled by authorities)
  • Market Observation Post System (real-time)
  • Participated in meetings organized by relevant authorities to understand policy changes and promptly adjust Company strategy to meet regulatory requirements
  • Responded formally to government inquiries and requests through official correspondence to ensure the accuracy and completeness of information
  • Cooperated with government inspections and audits by providing required documentation and implementing necessary corrective actions afterward
  • Disclosed material company information in a timely manner on the Market Observation Post System to ensure transparency

In addition to managing engagement with key stakeholders, Bora Pharmaceuticals maintains open communication and interaction with all stakeholder groups. An external communication mailbox is available on our official website, establishing transparent and diverse channels as we work with all stakeholders toward a sustainable future.

Communication Channels

Investor Contact Information

Spokesperson: Ms. Alice Wang, Vice President
Deputy Spokesperson: Ms. Nadiya Chen, Senior Manager, Investor Relations
Media Contact: Ms. Nadiya Chen
Phone: +886-2-2790-1555
Email: public01@bora-corp.com

Stock Affairs Agent

Name: Taishin Securities Co., Ltd.
Website: https://www.taishinbank.com.tw
Address: B1, No. 96, Section 1, Jianguo North Road, Zhongshan District, Taipei City 10489, Taiwan
Phone: +886-2-2504-8125

Customer Contact

Bora Pharmaceuticals provides professional CDMO services with advanced facilities that adhere to international standards, offering customers specialized and customized services.

Customer Contact: Ms. Weni Wang
Email: weni.wang@bora-corp.com

Supplier Contact

Bora Pharmaceuticals applies strict standards to supplier selection, with the aim of maintaining long-term and stable cooperation, and conducts periodic supplier audits and safety meetings to sustain stable production operations.

Supplier Contact: Ms. Ruby Chung
Email: ruby.chung@bora-corp.com

Employee Relations and Welfare

Bora Pharmaceuticals values employee rights. In addition to convening the Employee Welfare Committee regularly and holding communication meetings between managers and colleagues from time to time, we follow the UN Guiding Principles on Business and Human Rights, respect human rights and equal employment rights, and adhere to internationally aligned labor safety and health protection measures to build a friendly workplace. The Group believes that a stable, healthy and comfortable environment allows every employee to develop their career with confidence and realize their full potential. Where employee rights may be compromised, the Group provides effective and appropriate grievance mechanisms to ensure that the process is equitable and transparent.

Employee Contact: Ms. Ellen Chen
Email: hr80@bora-corp.com

Environmental Safety and Health

With sustainable operations as its goal, Bora Pharmaceuticals places emphasis on occupational safety, environmental protection, pollution prevention and other environmental, safety and health issues.

Environmental Safety and Health Contact: Mr. Miller Chang
Email: miller.chang@bora-corp.com